257
Views
1
CrossRef citations to date
0
Altmetric
Original articles

Extracting turkey coronaviruses from the intestinal lumen of infected turkey embryos yields full genome data with good coverage by NGS

, ORCID Icon, , , , , & show all
Pages 291-294 | Received 09 Apr 2021, Accepted 21 Feb 2022, Published online: 14 Mar 2022
 

ABSTRACT

Currently, turkey coronaviruses (TCoV) are isolated from homogenized intestines of experimentally infected embryos to ensure a maximum recovery of viral particles from all components of the intestines. However, the process of homogenization also ensures release of a significant amount of cellular RNAs into the sample that hinders downstream viral genome sequencing. This is especially the case for next generation sequencing (NGS) which sequences molecules at random. This characteristic means that the heavily abundant cellular RNA in the sample drowns out the minority viral RNA during the sequencing process and, consequently, very little to no viral genome data are obtained. To address this problem, a method was developed, in which 10 descendent isolates of the European strain of TCoV were recovered uniquely from the intestinal lumen without homogenization of the tissue. For nine out of 10 samples, NGS produced viral RNA reads with good coverage depth over the entire TCoV genomes. This is a much-needed new, simple and cost effective method of isolating TCoV that facilitates downstream NGS of viral RNA and should be considered as an alternative method for isolating other avian enteric coronaviruses in the interest of obtaining full-length genome sequences.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was partly funded by Agence National de Sécurité Sanitaire de l’Alimentation, l’Environnement et du Travail (ANSES) [grant number 180019], the “Région Bretagne”, the “Université Bretagne Loire” and the “Université de Rennes 1” (UNIR) [code of convention: 180019] and partly funded by the European Joint Programme One Health METASTAVA [no 773830].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.